Recombinant Adeno-Associated Virus-mediated rescue of function in a mouse model of Dopamine Transporter Deficiency Syndrome
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recombinant Adeno-Associated Virus-mediated rescue of function in a mouse model of Dopamine Transporter Deficiency Syndrome
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-18
DOI
10.1038/srep46280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted genetic manipulations of neuronal subtypes using promoter-specific combinatorial AAVs in wild-type animals
- (2015) Heinrich S. Gompf et al. Frontiers in Behavioral Neuroscience
- Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood
- (2014) Joanne Ng et al. BRAIN
- TAAR1-dependent effects of apomorphine in mice
- (2014) Ilya Sukhanov et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Missense dopamine transporter mutations associate with adult parkinsonism and ADHD
- (2014) Freja H. Hansen et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- N-terminal tagging of the dopamine transporter impairs protein expression and trafficking in vivo
- (2014) Laura M. Vecchio et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Ironing out VPS34 inhibition
- (2014) Timothy Marsh et al. NATURE CELL BIOLOGY
- The role of nitric oxide on visual-evoked potentials in MPTP-induced Parkinsonism in mice
- (2014) Sinem Aras et al. NEUROCHEMISTRY INTERNATIONAL
- Restoration of cocaine stimulation and reward by reintroducing wild type dopamine transporter in adult knock-in mice with a cocaine-insensitive dopamine transporter
- (2014) Haiyin Wu et al. NEUROPHARMACOLOGY
- Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: Role of D2 dopamine autoreceptors
- (2014) D. Leo et al. NEUROPHARMACOLOGY
- Adeno-associated virus serotypes 9 and rh10 mediate strong neuronal transduction of the dog brain
- (2013) G P Swain et al. GENE THERAPY
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
- (2013) R. T. Bartus et al. NEUROLOGY
- Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R1441G) transgenic mouse
- (2013) Brian P. Dranka et al. NEUROSCIENCE LETTERS
- Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism
- (2013) Gunhyuk Park et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Mechanisms of dopamine transporter regulation in normal and disease states
- (2013) Roxanne A. Vaughan et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Optogenetic stimulation of VTA dopamine neurons reveals that tonic but not phasic patterns of dopamine transmission reduce ethanol self-administration
- (2013) Caroline E. Bass et al. Frontiers in Behavioral Neuroscience
- Monoamine Transporter Structure, Function, Dynamics, and Drug Discovery: A Computational Perspective
- (2012) Sankar Manepalli et al. AAPS Journal
- Developmental changes in human dopamine neurotransmission: cortical receptors and terminators
- (2012) Debora A Rothmond et al. BMC NEUROSCIENCE
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Genetic Mapping and Exome Sequencing Identify Variants Associated with Five Novel Diseases
- (2012) Erik G. Puffenberger et al. PLoS One
- Gene Therapy for Aromatic L-Amino Acid Decarboxylase Deficiency
- (2012) W.-L. Hwu et al. Science Translational Medicine
- A specific subtype of Infantile Parkinsonism-dystonia identified
- (2011) E Fisher CLINICAL GENETICS
- Demon Voltammetry and Analysis software: Analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures
- (2011) Jordan T. Yorgason et al. JOURNAL OF NEUROSCIENCE METHODS
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study
- (2010) Manju A Kurian et al. LANCET NEUROLOGY
- Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease
- (2010) Shuwen Cao et al. Molecular Neurodegeneration
- A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease
- (2010) Shin-ichi Muramatsu et al. MOLECULAR THERAPY
- Expression of transgenes in midbrain dopamine neurons using the tyrosine hydroxylase promoter
- (2008) M S Oh et al. GENE THERAPY
- Model-Based 2.5-D Deconvolution for Extended Depth of Field in Brightfield Microscopy
- (2008) F. Aguet et al. IEEE TRANSACTIONS ON IMAGE PROCESSING
- Unregulated Cytosolic Dopamine Causes Neurodegeneration Associated with Oxidative Stress in Mice
- (2008) L. Chen et al. JOURNAL OF NEUROSCIENCE
- A FLEX Switch Targets Channelrhodopsin-2 to Multiple Cell Types for Imaging and Long-Range Circuit Mapping
- (2008) D. Atasoy et al. JOURNAL OF NEUROSCIENCE
- Dopaminergic Innervation of the Amygdala Is Highly Responsive to Stress
- (2003) Fiona M. Inglis et al. JOURNAL OF NEUROCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation